Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug.
PubMed Similar studies Analyze with GEO2RSRA Run Selector
PAK1 is a Therapeutic Target in Acute Myeloid Leukemia and Myelodysplastic Syndrome
PubMed Full text in PMC Similar studies Analyze with GEO2R
Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML
PubMed Similar studies Analyze with GEO2R
TRANSCRIPTOMIC PROFILING OF ASTROCYTES TREATED WITH THE RHO KINASE INHIBITOR FASUDIL REVEALS CYTOSKELETAL AND PRO-SURVIVAL RESPONSESTRANSFORMATION INDUCED BY THE RHO KINASE INHIBITOR FASUDIL.
Rho kinase inhibitor fasudil effect on forebrain astrocyte culture: time course
PubMed Similar studies GEO Profiles Analyze DataSet
Human KASUMI-1 cells: Control vs Radotinib (RD) 5uM
Effects of knockdown of ROCK1 and ZIPK on gene expression in cultured human vascular smooth muscle cells
Zipper-interacting protein kinase deficiency effect on coronary artery smooth muscle cells in vitro
PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet
Rho-associated kinase deficiency effect on coronary artery smooth muscle cells in vitro
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on